Global Exosome Technologies Market Growth Analysis 2024 –2033

Overview and Scope

Exosome technologies refer to the use of exosomes, which are small extracellular vesicles of endosomal origin, in various fields such as regenerative medicine, biotechnology, and biomedical research. Exosome technology has potential applications in diagnostics, particularly in liquid biopsy-based diagnostics and biomarker discovery projects. Exosomes can be used as diagnostic biomarkers for the early detection of diseases.

Sizing and Forecast

The exosome technologies market size has grown exponentially in recent years. It will grow from $0.06 billion in 2023 to $0.07 billion in 2024 at a compound annual growth rate (CAGR) of 26.7%. The growth in the historic period can be attributed to therapeutic advancements, isolation technique developments, research funding boost, regenerative medicine exploration, clinical trials inception.

The exosome technologies market size is expected to see exponential growth in the next few years. It will grow to ” $0.18 billion in 2028 at a compound annual growth rate (CAGR) of 27.0%. The growth in the forecast period can be attributed to regulatory progress, biomedical engineering innovations, clinical trials proliferation, regenerative medicine development, nanotechnology integration growth. Major trends in the forecast period include therapeutic advancements, diagnostic applications, nanotechnology integration, research funding surge, development of isolation techniques.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/exosome-technologies-global-market-report

Segmentation & Regional Insights

The exosome technologies market covered in this report is segmented –

1) By Exosome Type: Loaded Cargos, Non-Cargo
2) By Cell Source: HEK293 Cells, Mesenchymal Stem Cells (MSCs), Platelets, Erythrocytes, Natural Killer Cells, Other Cell Sources
3) By Application: Therapeutics, Diagnostics
4) By End-Users: Health Care Providers, Pharmaceutical And Biotechnology Companies, Other End-Users

North America was the largest region in the exosome technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global exosome technologies market report during the forecast period. The regions covered in the exosome technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10705&type=smp

Major Driver Impacting Market Growth

The rising prevalence of chronic diseases is expected to drive the growth of the exosome technologies market. Chronic disease refers to a health condition or disease that is persistent or long-lasting in its effects, usually lasting for three months or longer, and may get worse over time. The rising prevalence of chronic diseases demands exosome technologies that offer potential uses such as identifying disease-specific biomarkers and monitoring disease progression using exosome cargo analysis, targeted drug delivery, and immune modulation in chronic conditions. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based international resource for the scientific research community, the number of individuals aged 50 years and older having one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Furthermore, in July 2022, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, approximately 47%, or 11.6 million individuals in Australia, were estimated to be affected by at least one of the ten chosen chronic ailments. Therefore, the rising prevalence of chronic diseases is expected to propel the growth of the exosome technologies market.

Key Industry Players

Major companies operating in the exosome technologies market report are AEGLE Therapeutics, Aruna Bio Inc., Carmine Therapeutics Inc., Exosome Diagnostics Inc., Creative Biolabs Inc., Danaher Corporation, OmniSpirant Limited, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Anjarium Biosciences, NOVADIP Biosciences S.A., Exopharm Ltd., Organicell Regenerative Medicine Inc., Evox Therapeutics, Direct Biologics, ExoCan Healthcare Technologies Pvt. Ltd., ExoCoBio, ExonanoRNA LLC, ILIAS Biologics Inc., Illumina Inc., Invitrix Therapeutics, XOStem Inc., VivaZome Therapeutics Pty Ltd., Aethlon Medical Inc., Capricor Therapeutics, Codiak BioSciences, Exogenus Therapeutics, Exovita Biosciences, HansaBioMed Life Sciences, Hitachi Chemical Advanced Therapeutics Solutions

The exosome technologies market report table of contents includes:

1. Executive Summary

2. Exosome Technologies Market Characteristics

3. Exosome Technologies Market Trends And Strategies

4. Exosome Technologies Market – Macro Economic Scenario

 

5. Global Exosome Technologies Market Size and Growth

….

31. Global Exosome Technologies Market Competitive Benchmarking

32. Global Exosome Technologies Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Exosome Technologies Market

34. Exosome Technologies Market Future Outlook and Potential Analysis

 

35. Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model